Authors
Latest:
COVID-19: Therapeutics Under InvestigationJanita Good looks at some of the therapeutics currently under investigation and the issues they have highlighted in the context of a pandemic.
Latest:
Optimizing next-generation sequencing for precision oncology trialsThis article explores how optimizing next-generation sequencing (NGS) in oncology trials can enhance patient identification, boosts efficiency, and enables diverse recruitment.
Latest:
The Importance of Responsible and Transparent Communications in Pharma MarketingPharma marketing strategies that are both socially and ethically responsible can build long term success for the life sciences industry.
Latest:
Payers Believe Lowering Drug Prices While Improving Patient Access Is Possible—but There’s a CatchValue-based price for access (VBPA) may increase access of specialty drugs for patients.
Latest:
Are You Ready for the Telemedicine Revolution?A new patient journey is emerging. Gilda Sala, Trista Bridges, and Rune Soelvsteen offer easy steps to future-proof your company’s approach.
Latest:
Reducing Prescription Drug Costs for Seniors: The ABCs of ASP for Part DOutlining the steps to a payment approach for Medicare Part D drugs that provides savings for patients.
Latest:
Gross-to-Net is not just a process but a way for business growthDefining what Gross-to-Net mean and why it is important to Life Sciences companies; Identify who in the company benefits in utilizing information from GTN; Get insights to successfully define and manage GTN process
Latest:
In life sciences, the metaverse opportunity knocksHere are three mindsets for pharma companies to adopt now to reap the rewards of early action in the metaverse.
Latest:
Thriving ‘Beyond the Pill’: Closing Key Gap in Patient SupportWhy pharma needs to focus on improving—not just extending life.
Latest:
The Three Core Ingredients of Lasting Patient EngagementBiopharma marketers use experience to grow brands into fixtures in patient discourse
Latest:
Challenges of Patient Engagement in Atopic DermatitisHannah Brown & Elizabeth Baynton explore the atopic dermatitis patient-doctor dynamic and identify opportunities to optimize patient outcomes.
Latest:
Prospective Measures to Combat Rising Drug Prices in GermanyThis article provides an overview of potential tools being explored in Germany by Health Insurance Funds to better control drug prices and healthcare spend, offering insight into which measure may be implemented.
Latest:
The Future of Periodontal TreatmentAdvancements in periodontal disease could make way for expansions in the dental space and other medical fields.
Latest:
Remote Reliance: The Rise of Oncology Home CareWhile hurdles remain, home healthcare could deliver better patient-centered cancer care—providing improved outcomes, enhanced quality of life, and reduced strain on resources.
Latest:
Biopharma Needs a Health System Strategy to Secure Optimal Market AccessIn today’s pharmaceutical market access landscape, payers are not the sole decision-makers in utilization management development.
Latest:
Patient-Centricity in Biopharma: Selling Health Versus PillsDevesh Verma and Rebecca Lorenzo outline some the challenges and potential solutions to building a patient-centric culture
Latest:
IDMP in a COVID ContextLise Stevens explores what difference the ISO IDMP (Identification of Medicinal Products) data standards would have made in a COVID-19 context — in applications ranging from pharmacovigilance adverse event reporting and electronic prescribing to falsified medicines control.
Latest:
Why the Pandemic is Rewriting the Biopharma Rule BookChanges necessitated by COVID will drive unprecedented transformation of industry.
Latest:
China’s 2022 NRDL OutlookThe 2022 National Reimbursement Drug List will see more pressures for new inclusions on the one hand, and more certainties for renewals on the other. At the same time, the process is becoming more interactive and transparent.
Latest:
Fair Market Value vs. Current Market LeverageHow pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services
Latest:
A Brand Game-Changer? TikTok and Pharma MarketingIt’s time for pharma brands to recognize the potential of TikTok as a promotional platform and develop a strategy to not only stand out but make an impact.
Latest:
Climbing Health Care Costs Result in Elevated Employer VigilanceSoaring healthcare costs show little sign of slowing in 2024, with concerns growing about the affordability of medications and medical services.
Latest:
Are We Forgetting to Develop Vaccines for Diseases other than COVID?It's time to apply the same COVID-19 urgency to other devastating diseases, such as Alzheimer’s, write Andrea Pfeifer and William Mobley.
Latest:
3 ASCO Insights for Pharma CommunicatorsThe world’s largest cancer research meeting, the American Society of Clinical Oncology (ASCO) Annual Meeting, recently convened in person in Chicago after two years of being held virtually. Sara Baker and Kristine Austria Fan of Marina Maher Communications provide their takeaways from the meeting.
Latest:
Building Pharma and Lab Spaces in New Jersey 2021–Adapting to Changing NeedsNJ can regain leadership in pharma by offering modern lab spaces for biotech and other lab-based growth companies.
Latest:
Key Factors Attributing to a Successful Product LaunchWhat the c-suite should consider in today’s marketplace.
